Operative Treatment of 2-fragment-fractures (AO 11-A3) of the Proximal Humerus in the Elderly: Cement Augmented Locking Plate Philos vs. Proximal Humerus Nail MultiLoc
Launched by LMU KLINIKUM · Nov 19, 2015
Trial Information
Current as of May 02, 2025
Unknown status
Keywords
ClinConnect Summary
Because of the lack of clinical studies which compare cement augmented locking plates with multiplanar humeral nail systems after 2-part proximal humeral fractures, the decision of surgical method currently depends only on surgeons favour. Because only a randomized clinical trial (RCT) can sufficiently answer the question if one treatment option provides advantages compared to the other method we are planning to perform a RCT.
Investigators hypothesis: The cement augmented angle stable plate fixation system PhilosTM with augmentation (Depuy-Synthes) achieves significant differences concern...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age: ≤60 years or younger postmenopausal woman
- • 2-fragment-fracture according to AO-classification AO 11-A3
- • Signed informed consent
- • Patient can read and understand German
- Exclusion Criteria:
- • Refusal to participate in the study
- • Not Independent
- • Dementia and/or institutionalized
- • Does not understand written and spoken guidance German
- • Pathologic fracture or a previous fracture of the same proximal humerus
- • Alcoholism or drug addiction, e.g., in the emergency department, breathalyzer indicates blood alcohol concentration of more than 2%
- • Other injury to the same upper limb requiring surgery
- • Major nerve injury (e.g., complete radial- or axillary nerve palsy)
- • Rotator cuff tear arthropathy
- • Open fracture
- • Multi-trauma or -fractured patient
- • Fracture dislocation or head-splitting fracture
- • Non-displaced fracture
- • Isolated fracture of the major or minor tubercle
- • Gross displacement of the fracture fragments (no bony contact between fracture parts or the humeral shaft is in contact with the articular surface)
- • Any medical condition that excludes surgical treatment
- • Pregnancy
About Lmu Klinikum
LMU Klinikum is a leading academic medical center affiliated with Ludwig Maximilian University in Munich, Germany. Renowned for its commitment to innovative research and high-quality patient care, LMU Klinikum plays a pivotal role in advancing medical science through clinical trials and translational research. With a multidisciplinary approach, the institution collaborates with various stakeholders, including healthcare professionals, researchers, and industry partners, to facilitate groundbreaking studies that aim to improve therapeutic outcomes and enhance understanding of complex diseases. Its state-of-the-art facilities and expert clinical teams ensure the highest standards of safety and efficacy in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Munich, Bavaria, Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials